Animal Biotechnology Market

Animal biotechnology refers to the branch of biotechnology, which deals with the molecular biology techniques for producing genetically engineered animals (whose genome are modified), in order to make them suitable for pharmaceutical, industrial or agricultural applications. The genetically modified animals have improved growth rates, synthesized therapeutic proteins, and are resistant to various diseases. Increasing R&D by the major market players, rising regulatory approvals, and the rising focus toward cloning and transgenic animals are contributing to the market growth. However, high cost of research and development, and the ethical issues associated with animal biotechnology products may adversely affect the market growth.

Animal Biotechnology Market aims to provide a comprehensive presentation of the global market for Animal Biotechnology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Animal Biotechnology. Animal Biotechnology Market contains market size and forecasts of Animal Biotechnology in global, including the following market information:

Global Animal Biotechnology Market Revenue, 2018-2023, 2024-2029, ($ millions)

Global top five companies in 2022 (%)

The global Animal Biotechnology market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.

Diagnostic Tests Segment to Reach $ Million by 2029, with a % CAGR in next six years.

The global key manufacturers of Animal Biotechnology include Bayer AG, Merck &, Inc., Pfizer, Inc., Sanofi, Biogenesis Bago, Santa Cruz Biotechnology, Inc., Boehringer Inghlem, Virbac Inc. and Zoetis, etc. in 2022, the global top five players have a share approximately % in terms of revenue.

We surveyed the Animal Biotechnology companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Animal Biotechnology Market, by Type, 2018-2023, 2024-2029 ($ millions)

Global Animal Biotechnology Market Segment Percentages, by Type, 2022 (%)

Diagnostic Tests

Drugs

Reporductive & Genetic Produtcs

Vaccines

Global Animal Biotechnology Market, by Application, 2018-2023, 2024-2029 ($ millions)

Global Animal Biotechnology Market Segment Percentages, by Application, 2022 (%)

Preventive Care for Animals

Development of Animal Pharmaceuticals

Food Safety and Drug Development

Others

Global Animal Biotechnology Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)

Global Animal Biotechnology Market Segment Percentages, By Region and Country, 2022 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Animal Biotechnology revenues in global market, 2018-2023 (estimated), ($ millions)

Key companies Animal Biotechnology revenues share in global market, 2022 (%)

Further, the report presents profiles of competitors in the market, key players include:

Bayer AG

Merck &, Inc.

Pfizer, Inc.

Sanofi

Biogenesis Bago

Santa Cruz Biotechnology, Inc.

Boehringer Inghlem

Virbac Inc.

Zoetis

Outline of Major Chapters:

Chapter 1: Introduces the definition of Animal Biotechnology, market overview.

Chapter 2: Global Animal Biotechnology market size in revenue.

Chapter 3: Detailed analysis of Animal Biotechnology company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Animal Biotechnology in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: The main points and conclusions of the report.